Inventor

KAVANAUGH W MICHAEL

US20 patents

⚠️ This page may combine multiple inventors who share the name “KAVANAUGH W MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KAVANAUGH W MICHAEL

CHIRON CORP

Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers

Fibroblast growth factor receptor-immunoglobulin fusion

EGFH2 genes and gene products

Signaling inositol polyphosphate 5-phosphatases (SIPs)

PI 3-kinase fusion mutants and uses thereof

KGF polypeptide compositions

Antibodies to EGFH2 polypeptides

EGFH2 genes and gene products

NOVARTIS VACCINES & DIAGNOSTIC

Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers

Method of treating coronary artery disease by administering FGF-4

Angiogenically effective unit dose of FGF and method of administering

Method of treating coronary artery disease by administering FGF-9

BRENNAN THOMAS

Hair growth methods using FGFR3 extracellular domains

Method of promoting hair growth using FGFR4 extracellular domains

UNIV KYOTO

Human FGF-21 polypeptides

HARDING THOMAS

Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2

FIVE PRIME THERAPEUTICS INC

Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins

WHITEHOUSE MARTHA J

Method of treating coronary artery disease by administering FGF-5

HUNG DAVID T

Method for inducing angiogenesis in a heart of a patient

NOVARTIS VACCINES & DIAGNOSTICS INC

Method for inducing angiogenesis or vascular perfusion in the myocardium comprising administering FGF-2